FDA.reportPublic FDA data

alendronic acid 5 MG Oral Tablet

RxCUI
904425
RxNorm name
alendronic acid 5 MG Oral Tablet
Display name
alendronic acid 5 MG Oral Tablet
Full name
alendronic acid 5 MG Oral Tablet
Term type
SCD
Status
DailyMed mapping
Updated
2026-06-04 23:39:19

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
Alendronate SodiumALENDRONATE SODIUMAmneal Pharmaceuticals of New York LLCc23fb7fe-c6b9-4f77-bde7-992222b589d32021-02-02Warnings, Adverse reactionsExact identifier
rxcui: 904425

DailyMed RxNorm Mappings#

Set ID, RxNorm string, TTY table
Set IDRxNorm stringTTYSPL versionLabelEffective
c23fb7fe-c6b9-4f77-bde7-992222b589d3alendronic acid 5 MG Oral TabletSCD40These highlights do not include all the information needed to use ALENDRONATE SODIUM TABLETS safely and effectively. See full prescribing information for ALENDRONATE SODIUM TABLETS. ALENDRONATE SODIUM tablets, for oral use Initial U.S. Approval: 199520210202
c23fb7fe-c6b9-4f77-bde7-992222b589d3alendronic acid 5 MG (as alendronate sodium 6.53 MG) Oral TabletSY40These highlights do not include all the information needed to use ALENDRONATE SODIUM TABLETS safely and effectively. See full prescribing information for ALENDRONATE SODIUM TABLETS. ALENDRONATE SODIUM tablets, for oral use Initial U.S. Approval: 199520210202
c23fb7fe-c6b9-4f77-bde7-992222b589d3alendronate sodium 5 MG Oral TabletPSN40These highlights do not include all the information needed to use ALENDRONATE SODIUM TABLETS safely and effectively. See full prescribing information for ALENDRONATE SODIUM TABLETS. ALENDRONATE SODIUM tablets, for oral use Initial U.S. Approval: 199520210202
e6ffadda-2ace-4e99-8bb4-75631c54f39balendronate sodium 5 MG Oral TabletPSN120100305
e6ffadda-2ace-4e99-8bb4-75631c54f39balendronic acid 5 MG Oral TabletSCD120100305
e6ffadda-2ace-4e99-8bb4-75631c54f39balendronic acid 5 MG (as alendronate sodium 6.53 MG) Oral TabletSY120100305